News and Analysis

An ObamaCare deadline has collided with a fight over government funding, as Democrats are signaling they want Republicans to extend the law’s expiring premium subsidies

With positive Phase 1 results for the metabolic disorder drug MZE782, Maze Therapeutics plans to advance the small molecule to Phase 2 tests in phenylketonuria

Healthcare groups are pushing back on CMS’ proposed physician fee schedule for next year, raising concerns over payment cuts, administrative burdens and mandatory participation in